Reply: Pharmacokinetic and Pharmacodynamic Modifiers of EF5 Uptake and Binding.
Duke University Medical Center Box 3808Durham, NC 27710 E-mail: satish.chitneni@duke.edu.
Satish K
SK
Chitneni
Duke University Medical Center Box 3808Durham, NC 27710 E-mail: satish.chitneni@duke.edu.
Gerald T
GT
Bida
Duke University Medical Center Box 3808Durham, NC 27710 E-mail: satish.chitneni@duke.edu.
Michael R
MR
Zalutsky
Duke University Medical Center Box 3808Durham, NC 27710 E-mail: satish.chitneni@duke.edu.
Mark W
MW
Dewhirst
D000818:Animals; D002471:Cell Transformation, Neoplastic; D017341:Etanidazole / Q000031:analogs & derivatives*; D005462:Fluorine Radioisotopes; D006801:Humans; D006845:Hydrocarbons, Fluorinated / Q000378:metabolism*; D009369:Neoplasms / Q000378:metabolism* / Q000473:pathology*; D049268:Positron-Emission Tomography
D005462:Fluorine Radioisotopes; D006845:Hydrocarbons, Fluorinated; D017341:Etanidazole